Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia

被引：7

作者：

Bassler, Dirk ^{[1
]}

van den Anker, John ^{[2
,3
]}

机构：

[1] Univ Zurich, Univ Hosp Zurich, Dept Neonatol, Frauenklin Str 10, CH-8091 Zurich, Switzerland

[2] Univ Basel, Div Paediat Pharmacol & Pharmacometr, Childrens Hosp, Spitalstr 33, CH-4056 Basel, Switzerland

[3] Childrens Natl Med Ctr, Div Clin Pharmacol, 111 Michigan Ave NorthWest, Washington, DC 20010 USA

来源：

PEDIATRIC CLINICS OF NORTH AMERICA | 2017年 / 64卷 / 06期

关键词：

Bronchopulmonary dysplasia; Inhaled corticosteroids; Inhaled bronchodilators; Systemic corticosteroids; Dexamethasone; Hydrocortisone; Pharmacology; CHRONIC LUNG-DISEASE; LOW-DOSE HYDROCORTISONE; PRETERM INFANTS; PREMATURE-INFANTS; RANDOMIZED-TRIAL; CEREBRAL-PALSY; DOUBLE-BLIND; PREVENTION; THERAPY; PHARMACOKINETICS;

D O I：

10.1016/j.pcl.2017.08.012

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

All definitions of bronchopulmonary dysplasia (BPD) have limitations, and a new definition for the purpose of clinical research, benchmarking, and prognostic prediction is needed. Different inhaled and systemic drugs are currently used to prevent or treat BPD. Despite some positive effects on BPD, more information about the effects of inhaled corticosteroids is required to assess overall efficacy and associated risks. One needs to balance the risks of neurodevelopmental impairment owing to systemic corticosteroids against those of BPD itself. Future studies should, therefore, focus on infants with a very high risk of developing BPD and include pharmacokinetics and long-term developmental outcomes.

引用

页码：1355 / +

页数：14

共 50 条

[11] Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia: Balancing Risk and Reward
Jensen, Erik A.
JAMA PEDIATRICS, 2025, 179 (01) : 9 - 10
[12] Comparative effectiveness of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants
Slaughter, Jonathan L.
Klebanoff, Mark A.
Hade, Erinn M.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 457 - 457
[13] Estimating the effect of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants
Slaughter, Jonathan L.
Klebanoff, Mark A.
Hade, Erinn M.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2024, 38 (06) : 495 - 504
[14] Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants
Onland, Wes
Offringa, Martin
van Kaam, Anton
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (12):
[15] Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. systemic corticosteroids
Szabo, Hajnalka
Baraldi, Eugenio
Colin, Andrew A.
PEDIATRIC PULMONOLOGY, 2022, 57 (03) : 600 - 608
[16] Corticosteroids and bronchopulmonary dysplasia of the newborn
Chérif, A
Marrakchi, Z
Chaouachi, S
Boukef, S
Sfar, R
ARCHIVES DE PEDIATRIE, 2002, 9 (02): : 159 - 168
[17] Postnatal Corticosteroids for Bronchopulmonary Dysplasia
Jobe, Alan H.
CLINICS IN PERINATOLOGY, 2009, 36 (01) : 177 - +
[18] Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis
Hay, Susanne
Ovelman, Colleen
Zupancic, John A. F.
Doyle, Lex W.
Onland, Wes
Konstantinidis, Menelaos
Shah, Prakeshkumar S.
Soll, Roger
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (08):
[19] LATE (≥ 7 DAYS) SYSTEMIC POSTNATAL CORTICOSTEROIDS FOR BRONCHOPULMONARY DYSPLASIA: A METAANALYSIS
Zahid, Afra
Ayyan, Muhammad
Jafar, Uzair
Cheema, Huzaifa Ahmad
Eshan, Muhammad
Hussain, Ayesha
Ahmad, Amna Badar
Shahid, Abia
Tariq, Sunaina
Badar, Maryam
Szakmany, Tamas
CRITICAL CARE MEDICINE, 2023, 51 (01) : 476 - 476
[20] Systemic Postnatal Corticosteroids, Bronchopulmonary Dysplasia, and Survival Free of Cerebral Palsy
Doyle, Lex W.
Mainzer, Rheanna
Cheong, Jeanie L. Y.
JAMA PEDIATRICS, 2025, 179 (01) : 65 - 72

← 1 2 3 4 5 →